Key Takeaways
Inhaled insulin could work as well or better than injected insulin or insulin pumps, a new clinical trial saysMany patients using inhaled insulin achieved better control of blood sugar levels, on average, than those using traditional insulin methodsHowever, about a quarter of patients on inhaled insulin had their blood sugar levels worsen
MONDAY, June 24, 2024 (HealthDay News) — Inhaled insulin could be a better option than injections or pumps for some patients with type 1 diabetes, a new clinical trial shows.
Patients using inhaled insulin (Afrezza) plus long-lasting insulin degludec injections had better control over their blood sugar than those assigned to receive usual care, researchers report.
About 21% of those on inhaled insulin had a hemoglobin A1C improvement of greater than 0.5% during the study, compared with 5% of those on standard care, results show.
The clinical trial’s results “will impact diabetes management by providing healthcare providers and patients with an alternative …